ECM
IART icon

EMC Capital Management’s Integra LifeSciences IART Stock Holding History

EMC Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$74K Sell
5,986
-107
-2% -$1.42K 0.03% 209
2025
Q3 		$87K Hold
6,093
– – 0.04% 215
2025
Q2 		$75K Buy
+6,093
New +$88.5K 0.04% 223

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EMC Capital Management's IART Position: Q4 2025 in Review

EMC Capital Management reduced its Integra LifeSciences (IART) stake by 1.8% in Q4 2025, selling an estimated $1.42K and leaving 5,986 shares worth $74K. The position accounts for 0.03% of the portfolio, ranked #209.

EMC Capital Management first reported a position in IART in Q2 2025 and has held it in 3 quarters since. The position peaked at $87K in Q3 2025. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • EMC Capital Management held 5,986 shares of Integra LifeSciences worth $74K as of Q4 2025.
  • EMC Capital Management sold 107 Integra LifeSciences shares in Q4 2025, an estimated $1.42K.
  • Integra LifeSciences made up 0.03% of EMC Capital Management's portfolio in Q4 2025, its #209 holding.
  • EMC Capital Management first reported a position in Integra LifeSciences in Q2 2025 and has held it in 3 quarters since.
  • EMC Capital Management's Integra LifeSciences position peaked at $87K in Q3 2025.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.